Schrödinger, Inc. (NASDAQ:SDGR – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the nine ratings firms that are currently covering the stock, Marketbeat reports. Three investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average 12 month price target among analysts that have issued ratings on the stock in the last year is $42.80.
Several equities research analysts recently commented on the stock. KeyCorp decreased their price objective on shares of Schrödinger from $38.00 to $33.00 and set an “overweight” rating on the stock in a research report on Thursday, February 29th. Craig Hallum lowered their price target on shares of Schrödinger from $35.00 to $30.00 and set a “buy” rating on the stock in a research report on Thursday. TD Cowen assumed coverage on Schrödinger in a research report on Friday, January 26th. They set an “outperform” rating and a $42.00 price objective for the company. Bank of America lowered their target price on Schrödinger from $38.00 to $32.00 and set a “neutral” rating on the stock in a report on Thursday, February 29th. Finally, Citigroup cut their price target on Schrödinger from $39.00 to $37.00 and set a “buy” rating for the company in a report on Thursday.
View Our Latest Stock Analysis on SDGR
Insider Activity
Institutional Inflows and Outflows
Large investors have recently made changes to their positions in the company. Spire Wealth Management lifted its position in Schrödinger by 66.7% during the third quarter. Spire Wealth Management now owns 1,000 shares of the company’s stock valued at $28,000 after buying an additional 400 shares in the last quarter. International Assets Investment Management LLC lifted its holdings in shares of Schrödinger by 3,480.0% during the 4th quarter. International Assets Investment Management LLC now owns 1,790 shares of the company’s stock valued at $64,000 after acquiring an additional 1,740 shares in the last quarter. GAMMA Investing LLC purchased a new stake in Schrödinger during the 4th quarter worth $67,000. PNC Financial Services Group Inc. increased its holdings in Schrödinger by 186.7% in the 4th quarter. PNC Financial Services Group Inc. now owns 2,127 shares of the company’s stock valued at $76,000 after purchasing an additional 1,385 shares in the last quarter. Finally, Exchange Traded Concepts LLC raised its position in Schrödinger by 34.0% in the fourth quarter. Exchange Traded Concepts LLC now owns 4,244 shares of the company’s stock valued at $152,000 after purchasing an additional 1,076 shares during the period. 79.05% of the stock is owned by hedge funds and other institutional investors.
Schrödinger Trading Up 2.1 %
SDGR stock opened at $23.68 on Monday. The firm has a 50 day moving average of $26.09 and a 200-day moving average of $28.25. The company has a market cap of $1.71 billion, a price-to-earnings ratio of -12.60 and a beta of 1.58. Schrödinger has a 12-month low of $20.76 and a 12-month high of $59.24.
Schrödinger (NASDAQ:SDGR – Get Free Report) last released its quarterly earnings data on Wednesday, February 28th. The company reported ($0.32) earnings per share for the quarter, beating the consensus estimate of ($0.44) by $0.12. The firm had revenue of $74.10 million during the quarter, compared to the consensus estimate of $79.12 million. Schrödinger had a negative return on equity of 29.25% and a negative net margin of 75.94%. Schrödinger’s quarterly revenue was up 30.5% on a year-over-year basis. During the same period last year, the business posted ($0.39) EPS. Sell-side analysts forecast that Schrödinger will post -2.7 earnings per share for the current fiscal year.
Schrödinger Company Profile
Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.
Further Reading
- Five stocks we like better than Schrödinger
- How to Use High Beta Stocks to Maximize Your Investing Profits
- MarketBeat Week in Review – 4/29 – 5/3
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
Receive News & Ratings for Schrödinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Schrödinger and related companies with MarketBeat.com's FREE daily email newsletter.